Skip to search formSkip to main contentSkip to account menu

ormeloxifene

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Background: DUB is defined as abnormal uterine bleeding without any clinically detectable pelvic pathology. The present study was… 
2019
2019
Objective: To study the efficacy and safety of ormeloxifene in the medical management of AUB. Methods: 50 women with HMB who… 
2018
2018
Background: During women’s reproductive years, heavy menstrual bleeding (HMB) (abnormal uterine bleeding; AUB) is the most common… 
2016
2016
Method: The study was a prospective clinical observation undertaken to evaluate the efficacy of ormeloxifene in uterine fibroid… 
2016
2016
Breast pain or mastalgia is one of the most common benign disorders of breast. Several agents have been tried in the treatment of… 
2014
2014
To evaluate the efficacy of Ormeloxifene in DUB. Medical management of DUB is a challenging task and many drugs are available for… 
2014
2014
Objective: To assess the efficacy and safety of ormeloxifene (centchroman) in the medical management of menorrhagia. Materials… 
2012
2012
Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL Background: Cervical cancer is one of the most… 
2011
2011
ORMELOXIFNE - A new Treatment Modality in DUB Dr. Surendra Nath Panda, M.S. Professor of Obstetrics and Gynaecology M.K.C.G…